AML-437 Real-World Effectiveness of Enasidenib (ENA) in Older Patients With Relapsed/Refractory (R/R) Isocitrate Dehydrogenase-2 (IDH2)-Mutated Acute Myeloid Leukemia (AML)
Clinical Lymphoma Myeloma and Leukemia（2022）
关键词
AML,acute myeloid leukemia,enasidenib,isocitrate dehydrogenase-2 mutation,real-world,relapse
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要